Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Olema Pharmaceuticals Inc (OLMA)

Olema Pharmaceuticals Inc (OLMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032

/CNW/ -- According to a "highly troubling" new study, the rising number of cancer cases in young people is being attributed to "accelerated aging." Further...

ONCY : 1.1200 (+0.90%)
CELC : 16.80 (+0.24%)
OLMA : 9.52 (-3.25%)
BIO : 291.88 (-0.67%)
AZN : 77.11 (+0.27%)
ONC.TO : 1.51 (-2.58%)
Biotech's Developments in Race Against Rising Cancer Rates Revealed

USA News Group – According to a “highly troubling” new study, the rising number of cancer cases in young people is being attributed to “accelerated aging.” Further alarm is being spread by the...

ONCY : 1.1200 (+0.90%)
ONC.TO : 1.51 (-2.58%)
CELC : 16.80 (+0.24%)
OLMA : 9.52 (-3.25%)
BIO : 291.88 (-0.67%)
AZN : 77.11 (+0.27%)
Stocks Fall as Bond Yields Climb on Strong US Economic News

The S&P 500 Index ($SPX ) (SPY ) this morning is down -1.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.51%. Stock indexes this...

$SPX : 5,308.13 (+0.09%)
SPY : 530.06 (+0.12%)
$DOWI : 39,806.77 (-0.49%)
DIA : 398.10 (-0.46%)
$IUXX : 18,674.19 (+0.69%)
QQQ : 454.91 (+0.70%)
^BTCUSD : 69,495.27 (-0.01%)
ZNM24 : 109-010 (-0.06%)
HUM : 355.22 (-0.28%)
CVS : 57.40 (-0.49%)
UNH : 517.23 (-1.41%)
CNC : 77.57 (-0.63%)
Stocks Retreat as Bond Yields Jump on Diminished Fed Rate Cut Prospects

The S&P 500 Index ($SPX ) (SPY ) this morning is down -1.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.47%. Stock indexes this...

$SPX : 5,308.13 (+0.09%)
SPY : 530.06 (+0.12%)
$DOWI : 39,806.77 (-0.49%)
DIA : 398.10 (-0.46%)
$IUXX : 18,674.19 (+0.69%)
QQQ : 454.91 (+0.70%)
ZNM24 : 109-010 (-0.06%)
HUM : 355.22 (-0.28%)
CVS : 57.40 (-0.49%)
UNH : 517.23 (-1.41%)
ELV : 541.62 (-1.11%)
CNC : 77.57 (-0.63%)
How Recent Biotech Breakthroughs Are Changing the Fight Against Breast Cancer

USA News Group – More people are getting breast cancer this year. Around 300,000 women and 2,800 men will find out they have it. While 1 out of every 8 women will hear they have breast cancer sometime...

ONCY : 1.1200 (+0.90%)
ONC.TO : 1.51 (-2.58%)
PFE : 28.53 (-0.38%)
ARVN : 33.26 (+1.77%)
OLMA : 9.52 (-3.25%)
AZN : 77.11 (+0.27%)
How Recent Biotech Breakthroughs Are Changing the Fight Against Breast Cancer

USA News Group – More people are getting breast cancer this year. Around 300,000 women and 2,800 men will find out they have it. While 1 out of every 8 women will hear they have breast cancer sometime...

AVRN : 0.0125 (-30.56%)
ONCY : 1.1200 (+0.90%)
ONC.TO : 1.51 (-2.58%)
PFE : 28.53 (-0.38%)
ARVN : 33.26 (+1.77%)
OLMA : 9.52 (-3.25%)
AZN : 77.11 (+0.27%)
Olema Oncology Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Received Fast Track designation from U.S. FDA for OP-1250 for the treatment of ER+/HER2- metastatic breast cancerReported progress across OP-1250 clinical...

OLMA : 9.52 (-3.25%)
Olema Oncology Advances OP-1250 into Phase 2 Monotherapy Expansion in Patients with ER+/HER2- Advanced Breast Cancer

SAN FRANCISCO, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA), today announced the advancement...

OLMA : 9.52 (-3.25%)
Olema Oncology to Present at Canaccord Genuity 42nd Annual Growth Conference

SAN FRANCISCO, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA), a clinical-stage...

OLMA : 9.52 (-3.25%)
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN FRANCISCO, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema,” “Olema Oncology” or the “Company,” Nasdaq: OLMA), a clinical-stage...

OLMA : 9.52 (-3.25%)

Barchart Exclusives

3 Solar Stocks That Wall Street Likes Better Than SunPower
Despite SunPower’s impressive rally in recent sessions, Wall Street analysts remain skeptical about the stock's prospects and favor these three solar stocks instead. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar